Highlighting How Designing Compact Epigenome Editors Can Facilitate Clearance for Clinical Trials
Time: 11:30 am
day: Day Two
Details:
- Focus in on the importance of designing gene editors with delivery in mind
- Showcase strategies required to build a compact epigenetic gene editing platform
- Highlight that AAVs are well-studied in clinical trials so provide a good way forward, but a condensed gene editing platform opens the opportunity to use alternative delivery methods
